Additionally, treating AKI in the setting of sepsis with antibiotics may alter the microbiome, which has been shown to dampen ICI effectiveness by down‐regulating mucosal addressin cell adhesion molecule 1 (MAdCAM‐1) [41, 42]. This evidence concerns the gene MADCAM1 and Sepsis.